Senator inquires about FDA approval of ReGen knee implant

03/10/2009 | Wall Street Journal (free content), The

Sen. Chuck Grassley, R-Iowa, sent letters to ReGen Biologics and the FDA requesting information related to the agency's approval last fall of a knee implant made by ReGen. Grassley's inquiry comes after a report appeared in The Wall Street Journal on Friday about a controversy surrounding the approval.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC